Technology knows no borders, cooperation brings mutual benefits

On the morning of November 13, 2023, Dr. Nabil, a pharmaceutical PhD and General Manager of Algeria's Biorem Pharmaceutical Laboratory, led a core team of four technical personnel to visit the company for technical exchange and project cooperation inspection, accompanied by Li Xia, General Manager of Ningbo Hezhou Supply Chain Co., Ltd. The company's General Manager Yao Xiaodong, the head of the postdoctoral innovation practice base, the Haizhi Plan workstation, and the expert workstation warmly received them. Relevant personnel from the company's R&D, production, quality, sales, and scientific research technology platforms participated in the academic exchange meeting. Multiple parties focused on exploring cutting-edge technology and industry customer pain points, exchanging ideas, discussing experiences, and seeking directions and clarifying priorities for the next step of technological development.

General Manager Yao Xiaodong delivered a welcome speech on behalf of the company, introducing the company's development history, future plans, and the initiatives of "taking a new path, opening a new situation, and creating first-class standards," explaining the significance of this academic exchange and project inspection. They accompanied the visitors to tour the company's production workshop and scientific research laboratory, introduced the company's main products and semi-finished product export situation, and expressed hopes for broader and deeper project cooperation and collaborative innovation in the future.

Dr. Nabil, representative of Algeria's Biorem Pharmaceutical Laboratory, highly praised our company's advanced independent R&D technology and automated production line operation system, and eagerly hoped to establish a cooperative relationship with our company. The company's technical leader shared highlights of the company's work in global technological innovation, projects, and talent management practices; proposed future prospects and discussion topics for new product development. Experts attending the meeting engaged in in-depth exchanges and discussions with the visiting guests from the Algerian company on topics such as talent cultivation, project development, international exchange, and academic research based on their own work and research expertise. Dr. Nabil, pharmaceutical PhD and General Manager of Algeria's Biorem Pharmaceutical Laboratory, shared his personal feelings about participating in this academic exchange, expressed the desire to conduct in-depth academic cooperation with the company in areas such as tetanus antitoxin product technology and the biopharmaceutical health industry, and hoped to use this visit and exchange as an opportunity to further cooperate in international talent cultivation.

During the open discussion session, participants had lively exchanges and discussions on challenges in cross-cultural management at the company's Haizhi Plan workstation and the design of international talent management systems. The company provided detailed explanations in response to questions raised by the Algerian laboratory personnel.

Participants expressed that this technical exchange was very fruitful. Both sides will further strengthen communication and deepen understanding, aiming to achieve higher-level and high-quality cooperation in multiple fields such as talent cultivation and academic research in the future, promoting common development and achieving win-win cooperation.

This technical exchange meeting showcased the company's latest technological development directions and achievements. The Algerian experts brought new ideas, new trends, new technologies, and new experiences, injecting new vitality into the company's technological development. Our company will combine future development strategic needs with corporate development strategies, integrate cutting-edge technology research with industry-academia-research innovation, and bravely innovate in concepts, ideas, and cognition. Guided by the market, we aim to build a "high-quality and high-efficiency" biopharmaceutical industry, achieving sustainable development of science and technology through new technologies, new materials, and new processes. The company will also further enhance the sense of urgency and mission for technological innovation, leverage the innovation carrier role of the technology platform, further promote the two-way integration of the technology innovation chain and the industrial chain, and make technological innovation a bright business card for the company's high-quality development.